|
In a landmark move to further strengthen India’s position as a global leader in pharmaceuticals and healthcare, the Union Ministry of Commerce & Industry in collaboration with Pharmaceuticals Export Promotion Council of India (Pharmexcil) has announced the 11th edition of iPHEX 2025, to be held concurrently with the prestigious debut of Bharat Health 2025. The mega event is scheduled to take place from September 4 to 6, 2025, at Bharat Mandapam, New Delhi.
This concurrent hosting marks a first-of-its-kind confluence that will bring together the entire healthcare and pharma spectrum under one umbrella — from formulations, APIs, biotech, and medical devices to Ayush, nutraceuticals, diagnostics, plant & machinery, and healthcare services.
Online stall reservation for both the events has opened on April 14, 2025, via the official portal www.iphex-india.com, offering slot-based transparent and equitable access to over 700 exhibitor spaces.
“Bharat Health 2025 is a strategic platform to showcase India’s integrated healthcare capabilities to the world. The events are poised to attract thousands of domestic and global stakeholders, creating unparalleled networking, policy exchange, and trade facilitation opportunities. With iPHEX already having proven itself over 10 successful editions, the co-hosting with Bharat Health will elevate the experience and reach significantly,” stated K Raja Bhanu, Director General (DG) of Pharmexcil, while announcing the opening of online stall registrations.
Bharat Health 2025 is envisioned as a comprehensive platform that integrates all major healthcare segments with India's globally recognized pharmaceutical strength, embodied by iPHEX. Together, they aim to position India not only as the “Pharmacy of the World”, but also as a trusted global health solutions provider.
Over 400 international business delegates and thousands of Indian trade visitors are expected to attend. The profile of overseas attendees includes pharmaceutical importers and distributors, government procurement agencies, regulatory officials, trade chambers and associations, manufacturers & R&D organizations
These delegates will represent more than 120 countries, spanning NAFTA, EU, Africa, CIS, ASEAN, South Asia, LAC, Oceania, and WANA regions.
Exhibitor categories to be showcased include formulations (branded & generic), Active Pharmaceutical Ingredients (APIs), Vaccines, Biotech & Biosimilars, Veterinary, Nutraceuticals & Ayush, Excipients & Intermediates, Medical Devices & Diagnostics, Plant Machinery & Analytical Equipment, Services- (CRO, CDMO, Clinical Trials & Healthcare, Custom Synthesis), Regulatory & Tech Consultancy.
Since its inception, iPHEX has successfully attracted 50,000+ foreign delegates, hosted over 4,000 Indian exhibitors, facilitated business collaborations with 120+ countries and recorded over 1,00,000 trade visitors. The 2024 edition held at Greater Noida drew 20,000+ visitors and 400 international delegates, setting the benchmark for this year’s edition.
“With BHARAT HEALTH 2025 and iPHEX 2025, we are shaping a transformative platform that aligns with India’s G20 and global health leadership vision. We invite all industry stakeholders to be part of this historic convergence,” added Raja Bhanu.
|